Literature DB >> 30389464

Mutation Burden and I Index for Detection of Microsatellite Instability in Colorectal Cancer by Targeted Next-Generation Sequencing.

Jeong E Kim1, Sung-Min Chun2, Yong S Hong1, Kyu-Pyo Kim1, Sun Y Kim1, Jihun Kim2, Chang Ohk Sung2, Eun J Cho3, Tae W Kim4, Se Jin Jang5.   

Abstract

Next-generation sequencing (NGS) panels are widely used for defining tumor mutation profiles and determining treatment approaches. We performed targeted NGS with 382 colorectal cancer genes with known microsatellite instability (MSI). After exclusion of germline alterations, the load of somatic mutations and small insertion/deletion (indel) alterations were determined. In the test set, 79 patients with 41 microsatellite-stable (MSS) and 38 MSI tumors were included. There were 120 MSS and eight MSI-high tumors in the validation set. The number of somatic mutations of whole samples were distinguished into three groups: mutant functional polymerase epsilon catalytic subunit, MSI, and MSS tumors. The median numbers of somatic and indel mutations in MSI tumors were higher. The indel mutation to whole mutation ratio (I index) was higher in MSI tumors. Hypermutation and low I index of polymerase epsilon catalytic subunit mutant tumors, a somatic mutation load cut-off of ≥40, and an I index of ≥9% were selected as the criteria for detecting MSI tumors with high sensitivity and specificity. With the analysis of alteration patterns of homopolymer genes, a higher median number of homopolymer mutations in MSI tumors was observed. Mutated homopolymer ≥5 was selected as the criterion for detecting MSI tumors. MSI in colorectal cancer can be detected by targeted NGS panels with high sensitivity and specificity using somatic mutation load and I index.
Copyright © 2019 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30389464     DOI: 10.1016/j.jmoldx.2018.09.005

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  13 in total

1.  Insertion-deletion rate is a qualitative aspect of the tumor mutation burden associated with the clinical outcomes of gastric cancer patients treated with nivolumab.

Authors:  Hyung-Don Kim; Min-Hee Ryu; Young Soo Park; Sun Young Lee; Meesun Moon; Yoon-Koo Kang
Journal:  Gastric Cancer       Date:  2021-09-01       Impact factor: 7.370

2.  Characterization of Genomic Alterations in Colorectal Liver Metastasis and Their Prognostic Value.

Authors:  Xuanwen Bao; Kun Wang; Ming Liu; Bin Li; Hongwei Wang; Kemin Jin; Xiaoluan Yan; Hangyu Zhang; Quan Bao; Da Xu; Lijun Wang; Wei Liu; Yanyan Wang; Juan Li; Lijuan Liu; Weijia Fang; Baocai Xing
Journal:  Front Cell Dev Biol       Date:  2022-07-04

3.  Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas.

Authors:  Yoon Ah Cho; Deokgeun Kim; Boram Lee; Joon Ho Shim; Yeon-Lim Suh
Journal:  J Neurooncol       Date:  2021-04-17       Impact factor: 4.130

4.  Spontaneous mutations in the single TTN gene represent high tumor mutation burden.

Authors:  Ji-Hye Oh; Se Jin Jang; Jihun Kim; Insuk Sohn; Ji-Young Lee; Eun Jeong Cho; Sung-Min Chun; Chang Ohk Sung
Journal:  NPJ Genom Med       Date:  2020-01-14       Impact factor: 8.617

5.  Clinical Utility of a Fully Automated Microsatellite Instability Test with Minimal Hands-on Time.

Authors:  Miseon Lee; Sung-Min Chun; Chang Ohk Sung; Sun Y Kim; Tae W Kim; Se Jin Jang; Jihun Kim
Journal:  J Pathol Transl Med       Date:  2019-10-11

6.  High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer.

Authors:  Jeong Eun Kim; Jaeyong Choi; Chang-Ohk Sung; Yong Sang Hong; Sun Young Kim; Hyunjung Lee; Tae Won Kim; Jong-Il Kim
Journal:  Exp Mol Med       Date:  2021-03-22       Impact factor: 8.718

7.  Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance.

Authors:  Eunyoung Tak; Minhee Kim; Youngra Cho; Sueun Choi; Jihun Kim; Buhm Han; Hyung-Don Kim; Chloe Soo-Hyun Jang; Jeong Eun Kim; Yong Sang Hong; Sun Young Kim; Tae Won Kim
Journal:  Oncol Rep       Date:  2021-11-15       Impact factor: 3.906

8.  Immuno-genomic classification of colorectal cancer organoids reveals cancer cells with intrinsic immunogenic properties associated with patient survival.

Authors:  Eun Jeong Cho; Minsuh Kim; Daum Jo; Jihye Kim; Ji-Hye Oh; Hee Chul Chung; Sun-Hye Lee; Deokhoon Kim; Sung-Min Chun; Jihun Kim; Hyeonjin Lee; Tae Won Kim; Chang Sik Yu; Chang Ohk Sung; Se Jin Jang
Journal:  J Exp Clin Cancer Res       Date:  2021-07-13

9.  Tumor-Infiltrating Lymphocytes, Tumor Mutational Burden, and Genetic Alterations in Microsatellite Unstable, Microsatellite Stable, or Mutant POLE/POLD1 Colon Cancer.

Authors:  Ajaratu Keshinro; Chad Vanderbilt; Jin K Kim; Canan Firat; Chin-Tung Chen; Rona Yaeger; Karuna Ganesh; Neil H Segal; Mithat Gonen; Jinru Shia; Zsofia Stadler; Martin R Weiser
Journal:  JCO Precis Oncol       Date:  2021-05-12

10.  Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material.

Authors:  Elisabeth M P Steeghs; Leonie I Kroeze; Bastiaan B J Tops; Leon C van Kempen; Arja Ter Elst; Annemiek W M Kastner-van Raaij; Sandra J B Hendriks-Cornelissen; Mandy J W Hermsen; Erik A M Jansen; Petra M Nederlof; Ed Schuuring; Marjolijn J L Ligtenberg; Astrid Eijkelenboom
Journal:  BMC Cancer       Date:  2020-04-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.